Piramal Pharma Limited commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from a FY2022 base year.* Piramal Pharma Limited also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel and energy related activities, upstream transportation and distribution and use of sold products 25% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.